Use of Driving Tests to Evaluate Patient Performance on Oral Opioids
NCT00659035 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 450
Last updated 2026-01-08
Summary
Many patients seen at Pain Centers are advised not to drive if they are on long-term opioid medications. Although such advice is routinely given considering patients' safety, unnecessary restrictions to driving can cause inconvenience to the patients and delay their treatment. Such restrictions also pose social and legal questions to patients and physicians.
The investigators would like to test such patients' ability to drive under oral opioids using a driving simulator at the Pain Center. This simulator is like a video game with computer and a steering wheel to simulate real life driving. The driving simulator provides measure on several outcome measures, such as attention, reaction time, etc. allowing us to specifically address question pertaining to any cognitive or behavioral differences.
Conditions
Sponsors & Collaborators
-
Asokumar Buvanendran
lead OTHER
Principal Investigators
-
Asokumar Buvanendran, MD · Rush University Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain
NCT00214955 ·Status: COMPLETED ·Phase: PHASE3
-
A Brief Intervention for Patients on Opioids for Acute Pain
NCT05658926 ·Status: COMPLETED ·Phase: NA
-
The Effects of Minocycline in Opioid-maintained Patients
NCT02359006 ·Status: COMPLETED ·Phase: NA
-
Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use
NCT03248765 ·Status: TERMINATED
-
Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers
NCT03129347 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
NCT00228605 ·Status: COMPLETED ·Phase: PHASE3
-
Prescription Medication Interactions
NCT04315181 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)
NCT02192398 ·Status: TERMINATED ·Phase: NA
-
Pharmacokinetics of Nalbuphine Injection
NCT03826316 ·Status: COMPLETED ·Phase: PHASE4
-
Dosing Intervals of Opioid Medication for Chronic Pain
NCT04132011 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain
NCT00365898 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers
NCT02117583 ·Status: COMPLETED ·Phase: PHASE1
-
Usage and Plan of Care Changes Due to Drug Screenings
NCT02995278 ·Status: UNKNOWN
-
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
NCT00246532 ·Status: COMPLETED ·Phase: PHASE4
-
Ultra-low Dose Oral Ketamine for Chronic Pain in the Primary Care Setting
NCT02303847 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
NCT00343733 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Ketamine on Opioid-Induced Hyperalgesia
NCT00833755 ·Status: COMPLETED ·Phase: NA
-
Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning
NCT00930943 ·Status: COMPLETED ·Phase: PHASE4
-
Omnitram Pharmacokinetic Study In Healthy Volunteers
NCT02205554 ·Status: COMPLETED ·Phase: PHASE1
-
Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain
NCT01327326 ·Status: WITHDRAWN ·Phase: NA
-
Herb-Opioid Interactions
NCT00027014 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Abuse Potential of Cebranopadol in Humans
NCT05256108 ·Status: COMPLETED ·Phase: PHASE1
-
Addressing the Risks of Long-Term Opioid Therapy in Chronic Noncancer Pain
NCT03161795 ·Status: COMPLETED
-
Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use
NCT07218549 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1